| 产品详情 |
| Edit |   |
|---|
| Product Name | AF9 Blocking Peptide |
|---|
| Description | The AF9 Blocking Peptide has been validated for the following applications: Antibody Competition. |
|---|
| Size | 0.05 mg |
|---|
| Concentration | 0.2 mg/ml |
|---|
| Applications | Antibody Competition |
|---|
| Other Names | AF-9, AF9myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog);translocated to, 3, ALL1-fused gene from chromosome 9 protein, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog); translocatedto, 3, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 3, Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein, protein AF-9, YEATS domain-containing protein 3, YEATS3FLJ2035 |
|---|
| Gene, Accession, CAS # | MLLT3, Gene ID: 4300, SwissProt: NP_004520.1 |
|---|
| Catalog # | NB100-1566PEP |
|---|
| Price | |
|---|
| Order / More Info | AF9 Blocking Peptide from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|